Current Press

ProPhase Stock Quote

PRPH
Last
1.95
Change
-0.01 (-0.5%)

2015 Annual Report

ProPhase Labs to Release Second Quarter 2016 Results on Tuesday, August 9th

08-09-2016 16:25:41
Press Release

 

DOYLESTOWN, PA – August 5, 2016 - ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the second quarter, ended June 30, 2016, will be released after the market closes on Tuesday, August 9, 2016. A conference call will be held on Wednesday, August 10th, at 10:00 am EDT. ProPhase Labs Chairman and CEO, Ted Karkus, and COO/CFO Robert Cuddihy will provide a company overview including a review of activities and second quarter results. There will be a question and answer session following initial remarks. 
 
The conference call will be webcast live at:
at 10:00 AM (EDT) on Wednesday, August 10, 2016.
 
Participants wishing to ask questions may access the live call by dialing (844) 301-0501 conference ID # 62468030.  A replay of the conference call will be available for 90 days on the company website www.ProPhaseLabs.com

About ProPhase Labs
ProPhase Labs is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE® cold remedy brand as well as other cold and flu relief products. Cold-EEZE® cold remedy zinc gluconate lozenges are clinically proven to significantly reduce the duration of the common cold. Cold-EEZE® cold remedy customers include leading national chain, regional, specialty and local retail stores. ProPhase Labs has several wholly owned subsidiaries including a
manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE® cold remedy lozenges and fulfill other contract manufacturing opportunities. For more information visit us at www.ProPhaseLabs.com.
 
Investor Contact
Ted Karkus, Chairman and CEO
ProPhase Labs, Inc.
(215) 345-0919 x 0